What lies ahead of the global medical device industry?

Tariffs are complicating regulatory compliance and driving costs for manufacturers.

Ongoing global trade tensions are creating new regulatory challenges for the medical device industry due to shifting tariffs, according to GlobalData.

Tariffs aimed at protecting domestic industries are complicating regulatory compliance and increasing costs for manufacturers.

“For multinational manufacturers, managing compliance across several jurisdictions becomes increasingly burdensome under these conditions,” Elia Garcia, Medical Analyst at GlobalData, said.

Some manufacturers have already reported cost increases due to tariffs on imported parts and materials. In response, several firms are evaluating domestic manufacturing options to reduce trade exposure and streamline compliance.

“Regulatory timelines are stretched, innovation cycles are disrupted, and internal resources are redirected towards navigating evolving trade and compliance dynamics,” Garcia added.